US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi NVO 2x Daily ETF

13.75

-0.0756-0.55%

Post-market: 13.820.0756+0.55%16:10 EDT

Volume:16

Turnover:225

Market Cap:206.22K

PE:- -

High:13.75

Open:13.82

Low:13.75

Close:13.82

52wk High:27.19

52wk Low:13.75

Shares:15.00K

Float Shares:15.00K

Volume Ratio:0.18

T/O Rate:0.11%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Novo Nordisk says CagriSema delivers ‘superior’ weight loss in REIMAGINE 5 trial

Novo Nordisk Gets Regulatory Nod in Singapore for Wegovy Treatment of Certain Liver Ailments

MT Newswires Live

Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT

Market Chatter: Novo Nordisk Mulls Direct NYSE Listing to Boost US Profile

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Alcon (ALC)

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.89%

European Pharma Leaders Push for National Reforms to Boost Investment

Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss

Novo Nordisk (NVO) Receives a Hold from Jefferies

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

Hope Fuels Markets but Reality Could Bite

Novo Nordisk Investor Day Disappointed

Market Chatter: Novo Nordisk CEO Eyes M&A to Fill Gaps in Drug Portfolio

MT Newswires Live

Novo Stock (NVO): Deutsche Bank Keeps Sell Rating, Says Growth Strategy ‘Underwhelming on Multiple Fronts’

Novo Nordisk (0QIU) Receives a Hold from Berenberg Bank

Novo Nordisk Investors Remain Nervous, but Share Drop an Overreaction

Novo Nordisk's Underwhelming Investor Day Met with Punishing Response

Novo Nordisk's Share Fall After Investor Day Seems Harsh

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/NVOC/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NVOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOC\",,,,,undefined,":{"symbol":"NVOC","market":"US","secType":"STK","nameCN":"Corgi NVO 2x Daily ETF","latestPrice":13.7479,"timestamp":1790971200000,"preClose":13.8235,"halted":0,"volume":16,"hourTrading":{"tag":"盘后","latestPrice":13.8235,"preClose":13.7479,"latestTime":"16:10 EDT","volume":6,"amount":82.4874,"timestamp":1790971804945,"change":0.0756,"changeRate":0.005499,"amplitude":0},"delay":0,"changeRate":-0.005468947806271904,"floatShares":15000,"shares":15000,"eps":0,"marketStatus":"Market Closed","change":-0.0756,"latestTime":"10-02 16:00:00 EDT","open":13.8235,"high":13.7479,"low":13.7479,"amount":225,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1784001600000,"exchange":"CBOE","adjPreClose":13.8235,"nav":13.82,"aum":207300,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":13.8235,"preClose":13.7479,"latestTime":"16:10 EDT","volume":6,"amount":82.4874,"timestamp":1790971804945,"change":0.0756,"changeRate":0.005499,"amplitude":0},"volumeRatio":0.176991},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOC\",,,,,undefined,":{"symbol":"NVOC","floatShares":15000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.176991,"shares":15000,"dividePrice":0,"high":13.7479,"amplitude":0,"preClose":13.8235,"low":13.7479,"week52Low":13.7479,"pbRate":"--","week52High":27.1863,"institutionHeld":0,"latestPrice":13.7479,"eps":0,"divideRate":0,"volume":16,"delay":0,"ttmEps":0,"open":13.8235,"prevYearClose":24.92,"prevWeekClose":14.9092,"prevMonthClose":14.2471,"prevQuarterClose":14.2471,"fiveDayClose":14.9092,"twentyDayClose":22.7613},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOC\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669826694","title":"Novo Nordisk says CagriSema delivers ‘superior’ weight loss in REIMAGINE 5 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669826694","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669826694?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:40","pubTimestamp":1790174414,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) this week announced topline results from the phase 3 REIMAGINE 5 and REDEFINE 9 trials of once-weekly CagriSema, an investigatio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-says-cagrisema-delivers-superior-weight-loss-in-reimagine-5-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-says-cagrisema-delivers-superior-weight-loss-in-reimagine-5-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","NVOH","BK4532","NVOC","PPH","BK4585","NVO","BK4599","OZEM","LU0154236417.USD","NVOX","IE00BKVL7J92.USD","THNR","BK4007","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669109600","title":"Novo Nordisk Gets Regulatory Nod in Singapore for Wegovy Treatment of Certain Liver Ailments","url":"https://stock-news.laohu8.com/highlight/detail?id=2669109600","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669109600?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:39","pubTimestamp":1790152792,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) has won approval from Singapore authorities for the use of its weight-loss drug, Wegovy, to treat certain liver diseases, the drugmaker said Wednesday.Wegovy, a once-weekly injectab","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVOC","BK4007","LU0154236417.USD","OZEM","LU1093756168.USD","NVOX","THNR","BK4599","IE00BZ1G4Q59.USD","BK4585","BK4588","LU1093756325.SGD","BK4532","PPH","NVO","NVOH","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669177534","title":"Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT","url":"https://stock-news.laohu8.com/highlight/detail?id=2669177534","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669177534?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:21","pubTimestamp":1790151673,"startTime":"0","endTime":"0","summary":"UPDATE 1-Novo Nordisk open to direct New York listing, CEO Doustdar tells FTSept 23 (Reuters)-Novo NordiskNOVOb.COis open to considering a direct New York Stock Exchange listing, replacing the America","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL6N45F05A:2","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHIP","LU2471134796.USD","LU2462157665.USD","PPH","IE00BJJMRY28.SGD","VHT","TMED","IE0009355771.USD","OZEM","LU2324357040.USD","ILDR","GDOC","LU1868836591.USD","FTXH","MEDX","NVOH","WDNA","SGXZ99366536.SGD","LU0114720955.EUR","CANC","BK4534","LU1023059063.AUD","LU2168564065.EUR","LU0133085943.USD","LU0345770308.USD","FHLC","LU1623119135.USD","LU0320765992.SGD","PJP","IHE","IXJ","XLV","LLYZ","THNR","NVOX","NVO","LU0354030511.USD","LU2028103732.USD","TRUH","HRTS","JDOC","IYH","MEDI","AGNG","NVOC","IE00BFTCPJ56.SGD","CURE","RXL","LU0640476718.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669106133","title":"Market Chatter: Novo Nordisk Mulls Direct NYSE Listing to Boost US Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2669106133","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669106133?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:05","pubTimestamp":1790150726,"startTime":"0","endTime":"0","summary":"Novo Nordisk  signaled it may consider upgrading its New York listing as it looks to raise its profile in the US market, the Financial Times reported Wednesday, citing chief executive Mike Doustdar.Doustdar said he sees potential advantages in listing shares directly on the New York Stock Exchange rather than relying on American depositary receipts, though the company is not actively pursuing the move, according to the FT.The US accounts for more than half of Novo's revenue and most of its sales of diabetes and obesity treatments, according to the report.Novo Nordisk did not immediately respond to MT Newswires' request for comment.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BKVL7J92.USD","BK4588","LU1093756325.SGD","NVOC","IE00BZ1G4Q59.USD","NVOX","BK4585","PPH","THNR","BK4532","NVOH","BK4007","OZEM","NVO","LU1093756168.USD","BK4599","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669386103","title":"Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Alcon (ALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669386103","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669386103?lang=en_us&edition=fundamental","pubTime":"2026-09-23 14:50","pubTimestamp":1790146217,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novo Nordisk (NVO) and Alcon (ALC). Novo Nordisk (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-and-alcon-alc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-and-alcon-alc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","BK4532","LU1093756168.USD","LU1093756325.SGD","NVOH","PPH","ALC","IE00BKVL7J92.USD","NVO","NVOC","BK4007","THNR","BK4534","LU2265009873.SGD","BK4599","BK4198","BK4588","LU1804176565.USD","NVOX","BK4585","IE00BZ1G4Q59.USD","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669126717","title":"Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669126717","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669126717?lang=en_us&edition=fundamental","pubTime":"2026-09-23 01:15","pubTimestamp":1790097314,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares down 36c near $39.45. Options volume running well above average with 73k...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-down-0-89-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-down-0-89-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","IE00BZ1G4Q59.USD","PPH","NVOC","OZEM","BK4007","IE00BKVL7J92.USD","THNR","BK4532","NVOX","BK4599","BK4588","NVO","LU0154236417.USD","BK4585","LU1093756325.SGD","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669140420","title":"European Pharma Leaders Push for National Reforms to Boost Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2669140420","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669140420?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:14","pubTimestamp":1790086440,"startTime":"0","endTime":"0","summary":"Several drugmakers urged European authorities to increase health budgets and speed up approvals for new medicines, warning the region is losing out to the U.S. and China in the race to attract investm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","LU0889565916.HKD","LU2237443382.USD","IE00BFXG1179.USD","IE0002141913.USD","BK4532","LU0211331839.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU1267930573.SGD","BK4599","NVOH","RHHBY","THNR","LU2236285917.USD","LU2462157665.USD","PPH","IE00BKVL7J92.USD","LU0109394709.USD","BK4007","IE00B2B36J28.USD","LU2237443549.SGD","LU2237443465.HKD","LU2237443622.USD","SNY","LU2237443978.SGD","LU1093756325.SGD","IE00BZ1G4Q59.USD","OZEM","BK4568","LU0058720904.USD","LU0154236417.USD","NVOC","AZN","LU2089984988.USD","BK4585","LU0029864427.USD","LU0708994859.HKD","LU1829250122.USD","LU2237443895.HKD","LU0070302665.USD","LU0128525929.USD","LU2417539215.USD","LU2456880835.USD","03165","LU2468319806.SGD","IE00BJJMRZ35.SGD","GSK","LU0432979614.USD","LU1093756168.USD","BK4588","NVS","LU0208291251.USD","CANC","LU0289739699.SGD","GSK.UK","IE00BFTCPJ56.SGD","LU0320765489.SGD","BK4578","NVOX","IE00B4R5TH58.HKD","HRTS","NVO","AZNH","IE0009355771.USD","LU0310800379.SGD","GSKH","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142790","title":"Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142790","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142790?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:47","pubTimestamp":1790084874,"startTime":"0","endTime":"0","summary":"Eli Lilly and Novo Nordisk have been locked in a fierce battle to corner the weight-loss market, and while it is effectively a duopoly now, emerging competitors could soon challenge their...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Viking Therapeutics Stock Surges. It Could Challenge Lilly and Novo's Obesity Empire","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210536198.USD","LU2462591350.SGD","LU2211815571.USD","IE00BJLML261.HKD","LU0432979614.USD","SGXZ31699556.SGD","IE0004445015.USD","IE00BJJMRX11.SGD","LU0943347566.SGD","LU1814569148.SGD","LU2023250504.SGD","SG9999001176.USD","IE00B1XK9C88.USD","LU2023251221.USD","LU0320765059.SGD","LU2264538146.SGD","LU0787776722.HKD","SG9999014880.SGD","LU2237443382.USD","LLII","LU2602419157.SGD","LU2237443549.SGD","IE00BKDWB100.SGD","IE0002141913.USD","LU2168563687.JPY","LU1551013342.USD","JDOC","LU2089984988.USD","LU2236285917.USD","SGXZ51526630.SGD","LU1989771016.USD","LU2552382132.HKD","MHIP","LU1623119135.USD","LU0316494557.USD","FTXH","LU0323591593.USD","LU1868836591.USD","SGXZ99366536.SGD","BK4534","LU2265009873.SGD","BK4599","LU0256863902.USD","LU2491050071.SGD","LU1868837300.USD","LU2237443465.HKD","BK4588","LU2461242641.AUD","LU0823434740.USD","LLYZ","SG9999018865.SGD","LU1069344957.HKD","LU1720051017.SGD","LU1232071149.USD","TRUH","CURE","IYH","LU1366192091.USD","SG9999017495.SGD","LU0174119429.USD","BK4585","MEDX","LU1983299246.USD","SG9999013999.USD","LU2089284900.SGD","LU0096364046.USD","ELIS","LU2108987350.USD","IE00BFSS7M15.SGD","LU2237438978.USD","LU2271345857.HKD","LU0234572021.USD","LU2357305700.SGD","OZEM","LU0154236417.USD","LU2361044865.SGD","LU0672654240.SGD","LU0823434583.USD","LU0058720904.USD","LU2168564065.EUR","LU1093756168.USD","IE00B4R5TH58.HKD","LU1551013425.SGD","IE00BJJMRY28.SGD","LU1917777945.USD","LU2456880835.USD","LU1093756325.SGD","LU2746668461.USD","LU2750360641.GBP","LU2237443978.SGD","PPH","SG9999015986.USD","BK4581","BK4516","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","BK4533","LU0385154629.USD","NVOC","LU0114720955.EUR","LU1974910355.USD","LU1629891620.HKD","IE00BFTCPJ56.SGD","LU1720051108.HKD","LU0203201768.USD","LU0353189680.USD","LU1691799644.USD","LU2106854487.HKD","IE0009355771.USD","LU0158827781.USD","LU1064131342.USD","LU2168564495.EUR","LU1868836757.USD","LU0109391861.USD","LU0238689110.USD","LU0882574055.USD","VHT","IE00BFSS8Q28.SGD","SG9999014898.SGD","IHE","IE00BN29S564.USD","LU0823416689.USD","LU2491049909.HKD","LU0456855351.SGD","LU2063271972.USD","LU0354030438.USD","LU2750360997.AUD","IE00BK4W5M84.HKD","LU2471134523.USD","LU1057294990.SGD","ELIL","LU2756315664.SGD","LU1979441026.SGD","FHLC","SG9999015978.USD","LU2361045086.USD","LU0820562030.AUD","LU0640476718.USD","LU2023250330.USD","LU2896262040.SGD","LU1267930730.SGD","LU2361044949.HKD","LU2324357040.USD","SG9999014906.USD","LU1291159041.SGD","BK4532","LU0689472784.USD","LU0158827948.USD","LU2087625088.SGD","LU0198837287.USD","LU0256863811.USD","LU2471134879.HKD","MEDI","NVOH","LU1127390331.HKD","LU2168564149.EUR","LU0079474960.USD","LU0708995401.HKD","LU1868836914.USD","LU0882574139.USD","LU1023059063.AUD","SG9999001176.SGD","LU2112291526.USD","LU0097036916.USD","LU0006306889.USD","NVO","SG9999014914.USD","LU2471134796.USD","LU0683600562.USD","LU0094547139.USD","SG9999018857.SGD","LU0820561909.HKD","WDNA","LU0061475181.USD","LU2360106947.USD","IE00B7KXQ091.USD","LU0345770308.USD","SGXZ57979304.SGD","XLV","LU1280957306.USD","GDOC","VKTX","LU0225283273.USD","LU0471298777.SGD","LU2491050154.USD","LU0266013472.USD","LU0786609619.USD","IE00B2B36J28.USD","LU2111349929.HKD","GB00BDT5M118.USD","LU2471134952.CNY","LU2746668974.SGD","LU1145028129.USD","LU2237443622.USD","IE00BZ1G4Q59.USD","IXJ","LU1988902786.USD","LU1868837136.USD","LU0889565916.HKD","LU2552382058.USD","LU2756315318.SGD","TMED","LU0106261372.USD","LU1712237335.SGD","SG9999015945.SGD","CANC","LU1548497426.USD","LU1323610961.USD","IE00BKPKM429.USD","SG9999015952.SGD","IE0001KFT4U8.USD","LU0320765992.SGD","LU0109394709.USD","LU2028103732.USD","LU2168564222.USD","RXL","BK4139","IE00BKVL7J92.USD","LU0353189763.USD","LU2468319806.SGD","LU2237443895.HKD","LU2213496289.HKD","LU0345770993.USD","BK4007","IE0004445239.USD","ILDR","LLYX","LU0122379950.USD","LU0417517546.SGD","LU1035775433.USD","THNR","SGXZ81514606.USD","LU0354030511.USD","IE00BK4W5L77.USD","LLY","LU0289739699.SGD","IE00B4JS1V06.HKD","LU0820561818.USD","LU2552382215.SGD","LU0133085943.USD","PJP","IE0005OL40V9.USD","LU1061106388.HKD","AGNG","HRTS","LU0466842654.USD","LU0203202063.USD","LU1804176565.USD","NVOX","LU2417539215.USD","IE00BWXC8680.SGD","LU0471298694.HKD","LU0964807845.USD","IE00B775H168.HKD","LU2089283258.USD","LU2462157665.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142751","title":"Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142751","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142751?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:06","pubTimestamp":1790082402,"startTime":"0","endTime":"0","summary":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats upSept 22 (Reuters)-The weight-loss drug market is booming, with biotech firms racing to capture a slice of the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0O6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLII","LU1989771016.USD","NVOX","LU1868837300.USD","SG9999018857.SGD","LU0823434583.USD","LU2468319806.SGD","BK4585","LU1145028129.USD","IE0001KFT4U8.USD","BK4588","IE00B7KXQ091.USD","ELIS","LU2108987350.USD","LU0354030511.USD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU1868836914.USD","SG9999014914.USD","GDOC","LU0061475181.USD","LU2471134879.HKD","LU0889565916.HKD","BK4532","LU2361044865.SGD","LU1023059063.AUD","LU0203202063.USD","LU2746668974.SGD","SG9999013999.USD","LU0320765059.SGD","LU0466842654.USD","LU1720051017.SGD","OZEM","LU2089284900.SGD","LU2491050154.USD","SGXZ51526630.SGD","SG9999018865.SGD","LU0079474960.USD","IE0002141913.USD","JDOC","LU1061106388.HKD","IXJ","IE00BJJMRX11.SGD","LU0225283273.USD","LU2111349929.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1814569148.SGD","LU2456880835.USD","LU2106854487.HKD","PPH","LU1366192091.USD","LU2023250504.SGD","BK4599","IE00BZ1G4Q59.USD","VHT","LU0471298777.SGD","AGNG","LU2237443622.USD","LU0109394709.USD","LU2168564222.USD","LU2168564495.EUR","LU2462591350.SGD","IE0009355771.USD","LU0094547139.USD","IE00BKDWB100.SGD","SG9999017495.SGD","FHLC","LU2471134796.USD","IE0005OL40V9.USD","LU2552382215.SGD","LU1868837136.USD","MHIP","LU0683600562.USD","LU1974910355.USD","LU0096364046.USD","CURE","SGXZ57979304.SGD","LU0786609619.USD","IE00BFSS8Q28.SGD","BK4581","NVO","LU0787776722.HKD","LU1868836591.USD","LU0058720904.USD","LLYZ","LU0174119429.USD","LU2168564149.EUR","IE00BJJMRY28.SGD","LU2265009873.SGD","LU2471134952.CNY","XLV","LU0133085943.USD","LU2360106947.USD","LU0882574055.USD","HRTS","TMED","IE0004445015.USD","LU0689472784.USD","IE0004445239.USD","LU0256863811.USD","LU0672654240.SGD","SG9999014906.USD","SGXZ81514606.USD","LU0820561818.USD","LU2324357040.USD","LU2063271972.USD","LU0823416689.USD","LU0353189680.USD","IE00B1XK9C88.USD","RXL","PJP","SG9999001176.USD","LU0345770308.USD","SG9999014880.SGD","LU0266013472.USD","LU0456855351.SGD","LU2168564065.EUR","LU2750360641.GBP","LU1551013342.USD","GB00BDT5M118.USD","LU2461242641.AUD","LU2471134523.USD","LU0203201768.USD","LU1069344957.HKD","LU2756315664.SGD","IE00BKVL7J92.USD","LU1323610961.USD","LU0882574139.USD","IE00BFSS7M15.SGD","LU0198837287.USD","LU0943347566.SGD","LU0471298694.HKD","LU0234572021.USD","LU2361044949.HKD","LU0006306889.USD","LU0353189763.USD","LU1868836757.USD","LU1232071149.USD","LU2089984988.USD","BK4534","LU1057294990.SGD","NVOH","LU2491050071.SGD","LU2896262040.SGD","LU2023250330.USD","LU0964807845.USD","LU0320765992.SGD","LU2237443549.SGD","MEDX","LU1720051108.HKD","LU2746668461.USD","LU0354030438.USD","IE00BFTCPJ56.SGD","LU0708995401.HKD","LU2236285917.USD","LU0385154629.USD","LU0158827781.USD","IHE","LU1267930730.SGD","SG9999001176.SGD","LU0417517546.SGD","LU0106261372.USD","LU2417539215.USD","TRUH","ILDR","SGXZ99366536.SGD","LU0345770993.USD","LU0820562030.AUD","SG9999015986.USD","LU1623119135.USD","LU0154236417.USD","LU2491049909.HKD","IE00BK4W5M84.HKD","CANC","LU1551013425.SGD","LU0640476718.USD","LU2237443978.SGD","WDNA","IE00BJT1NW94.SGD","SGXZ31699556.SGD","LU1064131342.USD","LU0109391861.USD","LU2112291526.USD","LU2361045086.USD","LU2750360997.AUD","LU2462157665.USD","LU2211815571.USD","LU0114720955.EUR","IE00BWXC8680.SGD","SG9999015978.USD","LU0238689110.USD","SG9999014898.SGD","LU0256863902.USD","LU2213496289.HKD","LU2237443382.USD","IYH","LU0122379950.USD","LU1127390331.HKD","LU2028103732.USD","IE00B2B36J28.USD","LU2089283258.USD","FTXH","LU1093756168.USD","BK4533","LU2271345857.HKD","LU0316494557.USD","IE00B4JS1V06.HKD","LU2087625088.SGD","LU1548497426.USD","SG9999015945.SGD","LU0210536198.USD","LU1291159041.SGD","BK4516","LLY","IE00BK4W5L77.USD","LU0432979614.USD","BK4007","LU1691799644.USD","LU2023251221.USD","LU2602419157.SGD","NVOC","IE00BN29S564.USD","MEDI","IE00BJLML261.HKD","LU0158827948.USD","LU1035775433.USD","LU0097036916.USD","LU1804176565.USD","LLYX","THNR","LU2237443895.HKD","IE00BKPKM429.USD","LU2756315318.SGD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU2237438978.USD","LU2264538146.SGD","LU0289739699.SGD","LU1988902786.USD","LU1629891620.HKD","LU1983299246.USD","LU1093756325.SGD","SG9999015952.SGD","LU1979441026.SGD","IE00B1BXHZ80.USD","LU2552382058.USD","LU2552382132.HKD","LU2357305700.SGD","IE00B775H168.HKD","LU1280957306.USD","LU0323591593.USD","LU1917777945.USD","ELIL","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174429461","title":"Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1174429461","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174429461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082018,"startTime":"0","endTime":"0","summary":"Viking Therapeutics (VKTX.US) saw its shares spike nearly 50% in Tuesday's premarket trading after the biotech announced that its experimental obesity drug, VK2735, helped patients maintain most of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","THNR","BK4007","NBDS","PINK","BK4139","BK4599","TRUH","BK4585","IYH","RSPH","FXH","OZEM","FHLC","NVOH","PJP","VKTX","LENZ","MEDI","BK4539","CURE","XLVI","NVOX","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142475","title":"Novo Nordisk (NVO) Receives a Hold from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142475?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:56","pubTimestamp":1790081803,"startTime":"0","endTime":"0","summary":"Jefferies analyst maintained a Hold rating on Novo Nordisk today and set a price target of $42.20. In addition to Jefferies, Novo Nordisk also rece...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-nvo-receives-a-hold-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-nvo-receives-a-hold-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","BK4007","PPH","THNR","BK4585","BK4599","BK4588","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVOC","NVOH","NVO","NVOX","OZEM","LU1093756168.USD","LU0154236417.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669445261","title":"Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669445261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669445261?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:22","pubTimestamp":1790079720,"startTime":"0","endTime":"0","summary":"Eli Lilly and Novo Nordisk have been locked in a fierce battle to corner the weight-loss market, and while it is effectively a duopoly now emerging competitors could soon challenge their lead.Seizing ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","SG9999018865.SGD","LU0471298777.SGD","LU1974910355.USD","LU0058720904.USD","LU1979441026.SGD","LU2168564065.EUR","LU2023251221.USD","LU1064131342.USD","TRUH","LU0820562030.AUD","JDOC","LU0094547139.USD","LU1868836757.USD","IE00B4JS1V06.HKD","LU2168563687.JPY","LU1983299246.USD","LU2361045086.USD","SGXZ81514606.USD","LU2168564495.EUR","LU2265009873.SGD","LU1720051108.HKD","CURE","LU0225283273.USD","LU0787776722.HKD","SG9999014914.USD","LU1712237335.SGD","SG9999014880.SGD","LU2108987350.USD","LU0133085943.USD","LU0154236417.USD","LU1917777945.USD","MHIP","LU2462157665.USD","LU0266013472.USD","GB00BDT5M118.USD","LLYZ","LU1145028129.USD","LU2112291526.USD","LU2357305700.SGD","LU0238689110.USD","IE00BKVL7J92.USD","LU1280957306.USD","LU2089284900.SGD","LU2237443978.SGD","SGXZ31699556.SGD","IE00BJT1NW94.SGD","LU1720051017.SGD","LU2063271972.USD","LU2896262040.SGD","LU2491050154.USD","SGXZ99366536.SGD","BK4516","LU0122379950.USD","LU0316494557.USD","ELIS","TMED","SG9999017495.SGD","IE0004445239.USD","LU0096364046.USD","LU2602419157.SGD","LU2360106947.USD","LU2106854487.HKD","LU2462591350.SGD","IE00BFSS8Q28.SGD","LU2471134952.CNY","LU2750360641.GBP","LU0345770993.USD","SG9999015978.USD","IE00BWXC8680.SGD","IE00B775H168.HKD","LU2264538146.SGD","LU0109394709.USD","LU2237443622.USD","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU1804176565.USD","LU2087625088.SGD","LU2236285917.USD","LU0354030511.USD","LU1323610961.USD","LU2211815571.USD","WDNA","SG9999018857.SGD","VHT","LU1988902786.USD","SG9999014898.SGD","IE00B1XK9C88.USD","LU0256863811.USD","LU1366192091.USD","NVO","PPH","FHLC","LLII","ELIL","LU2089984988.USD","SG9999015952.SGD","LU2213496289.HKD","SGXZ57979304.SGD","IE00BJJMRY28.SGD","LU0683600562.USD","IE00BJJMRX11.SGD","LU0820561909.HKD","IE00BFTCPJ56.SGD","NVOC","SGXZ51526630.SGD","LU0158827948.USD","LU2168564222.USD","NVOH","GDOC","IE0009355771.USD","LU0345770308.USD","LU0289739699.SGD","LU0466842654.USD","LU2237443382.USD","LU0114720955.EUR","LU0708995401.HKD","LU0882574055.USD","LU0210536198.USD","LU0882574139.USD","MEDI","LU0943347566.SGD","LU1868837300.USD","IE0001KFT4U8.USD","LU0256863902.USD","LU2471134796.USD","BK4139","LU0061475181.USD","LU2028103732.USD","VKTX","BK4585","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU1868836591.USD","IE00BKPKM429.USD","LU1069344957.HKD","LU1127390331.HKD","LU1814569148.SGD","LU2471134523.USD","LU0079474960.USD","LU1267930730.SGD","LU2756315664.SGD","MEDX","IXJ","BK4588","LU0203202063.USD","LU0432979614.USD","LU1061106388.HKD","LU2491050071.SGD","LU0203201768.USD","BK4533","LU0353189680.USD","LU1023059063.AUD","LU1232071149.USD","IE00BK4W5M84.HKD","LU2456880835.USD","LU1093756325.SGD","LU0417517546.SGD","IE00B7KXQ091.USD","LU2417539215.USD","IE00BN29S564.USD","LU2023250330.USD","LU1551013342.USD","LU1868836914.USD","IE00BFSS7M15.SGD","ILDR","LU0823416689.USD","LU2089283258.USD","THNR","IE00BK4W5L77.USD","LU0964807845.USD","LU2111349929.HKD","LU0471298694.HKD","HRTS","LU0786609619.USD","LU1868837136.USD","XLV","LU1035775433.USD","LU0234572021.USD","LU0889565916.HKD","FTXH","LU0823434583.USD","LU0820561818.USD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU2552382132.HKD","SG9999015945.SGD","LU2023250504.SGD","LU2324357040.USD","LU1551013425.SGD","NVOX","BK4534","LU0672654240.SGD","LU1629891620.HKD","LU2746668974.SGD","LU2750360997.AUD","IE0004445015.USD","CANC","IE00B4R5TH58.HKD","03165","IE00BKDWB100.SGD","LU0320765992.SGD","LU1548497426.USD","LU1691799644.USD","BK4599","BK4581","LU0320765059.SGD","LU2168564149.EUR","RXL","SG9999001176.SGD","IYH","LU0354030438.USD","LU2237443549.SGD","IE0002141913.USD","AGNG","LU0640476718.USD","LU2271345857.HKD","LU0174119429.USD","LU0158827781.USD","LU2468319806.SGD","LU0385154629.USD","LU2756315318.SGD","SG9999014906.USD","LU2361044865.SGD","LU0456855351.SGD","LU0198837287.USD","SG9999015986.USD","IHE","LU2746668461.USD","PJP","LU2552382058.USD","LU1291159041.SGD","SG9999001176.USD","LU1623119135.USD","LU2491049909.HKD","LU2552382215.SGD","LU0689472784.USD","LU2237443465.HKD","SG9999013999.USD","IE00BJLML261.HKD","LLYX","LU2471134879.HKD","LU1989771016.USD","IE0005OL40V9.USD","LU0097036916.USD","LU2361044949.HKD","LU2237438978.USD","LLY","LU0106261372.USD","BK4007","RHHBY","LU0109391861.USD","OZEM","LU0353189763.USD","LU0323591593.USD","LU2461242641.AUD","LU2237443895.HKD","LU0823434740.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141342","title":"Hope Fuels Markets but Reality Could Bite","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141342","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141342?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:51","pubTimestamp":1790077860,"startTime":"0","endTime":"0","summary":"Good morning and welcome to another hopeful day for markets as Iran lifts Wall Street's spirits.Stocks looked set to continue their positive start to the week as falling oil prices seemed to offset a ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336760.USD","IE0034235303.USD","IE0002270589.USD","IE0004445015.USD","IE00BJJMRX11.SGD","LU2023250504.SGD","METG","METW","LU1699723380.USD","LU0787776722.HKD","CBOJ","IDRV","CBXJ","MNRS","LU0552385451.USD","LU1935042991.SGD","LU1303367103.USD","SGXZ51526630.SGD","LU1989764664.SGD","DFII","SGXZ99366536.SGD","IE00BSNM7G36.USD","LU0323591593.USD","LU0072461881.USD","LU0433182093.SGD","IE00B19Z3581.USD","LU2148611432.USD","BK4602","LU2458330243.SGD","LU1564329032.USD","BRRR","LU1069344957.HKD","LU0056508442.USD","LU0174119429.USD","04335","LU1951200564.SGD","LU0211331839.USD","LU0096364046.USD","LU2357305700.SGD","IE00BMPRXR70.SGD","LU0823414478.USD","LU0077335932.USD","LU0154236417.USD","LU2361044865.SGD","LU2168564065.EUR","BK4592","BK4566","LU2420271590.USD","LU1093756168.USD","BCCC","DEFI","IE00BJJMRY28.SGD","LU1093756325.SGD","LU0149725797.USD","IE00B5949003.HKD","LU2272731782.SGD","LU2463028550.USD","LU2244417387.USD","IE00B1BXHZ80.USD","LU2237957902.USD","LU2487616109.SGD","LU0081259029.USD","XBTY","LTL","LU0130517989.USD","GXPC","TSLT","LU2106854487.HKD","LU1064131342.USD","LU0082616367.USD","LU0310799852.SGD","LU2317271919.USD","LU1778281490.HKD","CBOY","SG9999015978.USD","HODL","LU1267930730.SGD","LU1815333072.USD","BTRN","LU1316542783.SGD","LU2087625088.SGD","BAGY","LU2430703178.SGD","LU0210528500.USD","GBTC","LU2065171311.SGD","BK4574","LU0256863811.USD","VOX","LU0321505439.SGD","LU0708995401.HKD","LU1670711123.USD","LU0882574139.USD","TSLR","BK4529","LU0097036916.USD","AMUU","LU2097829019.USD","HK0000304805.HKD","QQQA","LU1066051498.USD","LU1301847155.USD","SG9999004303.SGD","LU0203345920.USD","LU0820561909.HKD","SG9999018857.SGD","LU0061475181.USD","PSI","SG9999002232.USD","LU1880398471.USD","LU1674673691.USD","LU0130102774.USD","LU1066053197.SGD","LU2089985449.USD","LU2471134952.CNY","YBTC","LU0208291251.USD","LU1670710588.SGD","LU2290526834.HKD","BK4141","AMD","LU2065171402.SGD","OGIG","LU1074936037.SGD","WATS","LU2552382058.USD","LU0528227936.USD","LU0792757196.USD","LU0068578508.USD","IE00BMPRXQ63.HKD","GAMR","LU2168564222.USD","AIS","LU2404859667.USD","LU0353189763.USD","LU2355687059.USD","LU0784384876.USD","LU2404859741.USD","META","LU1861558580.USD","BK4007","NULC","LU0444971666.USD","MAXI","METU","IE00BJTD4V19.USD","LU1880398554.USD","INTW","AMDC","BITX","WISE","LU1670628061.USD","IE0003U64NQ7.SGD","CHAT","LU0061474960.USD","IE00BWXC8680.SGD","LU0964807845.USD","CRSH","SMOG","LU0210533765.USD","LU0210536198.USD","LU1267930227.SGD","SGXZ31699556.SGD","LU1814569148.SGD","HK0000304797.USD","LU0724617625.USD","IE00B4YYXB79.USD","LU2360106780.USD","FBY","LU1823568750.SGD","IE00B3SWFQ91.USD","LU2473716301.USD","IE00BKDWB100.SGD","LU2860962120.EUR","ELOL","LU2125154778.USD","LU2236285917.USD","LU1489326972.SGD","LU2505996509.AUD","LU2265009873.SGD","LU0823421333.USD","IE00B19Z8X17.USD","LU2720916845.USD","BK4527","BK4588","LU0823434740.USD","LU1720051017.SGD","LU0162691827.USD","LU1267930490.SGD","LU1366192091.USD","LU0859254822.USD","IE0009356076.USD","OZEM","FTXL","IE000MB6IJN5.SGD","LU0080751232.USD","07766","LU0823434583.USD","LU1119994496.HKD","IE00B19Z8W00.USD","SOXX","LU2023250843.SGD","IE000M9KFDE8.USD","BTCL","LU0310800965.SGD","SMETAmain","SG9999015986.USD","BK4581","LU1861220033.SGD","LU0265550359.USD","CBXO","LU2322448957.HKD","LU0788109477.HKD","LU1429558221.USD","TESC","GB00B4QBRK32.GBP","TEK","LU0203201768.USD","LU0353189680.USD","BK4551","IE00BQXX3F31.USD","TSLQ","TSII","LU0476273544.USD","TRFK","LU2063271972.USD","LU0170899867.USD","IE00BK4W5M84.HKD","LU2471134523.USD","LU1242518931.SGD","LU0251142724.SGD","LU1979441026.SGD","LU1732799900.SGD","WBD","LU2242650005.HKD","SG9999014906.USD","AMDU","BK4532","HK0000914660.USD","LU0689472784.USD","TESL","IE000W1ABFV2.USD","LU0070217475.USD","NVOH","LU1127390331.HKD","LU2168564149.EUR","TSLG","CBTJ","LU0006306889.USD","LU0823411888.USD","LU1914381329.SGD","LU0784385840.USD","LU1201861249.SGD","LU1280957306.USD","LU0444973449.USD","IE0009G5SDU7.USD","GB00BDT5M118.USD","LU0690374615.EUR","BTCZ","LU2746668974.SGD","LU1046421795.USD","IETC","LU0128525689.USD","LU0348723411.USD","IE00BMPRXN33.USD","SG9999015945.SGD","LU1564329115.USD","LU2764262908.HKD","TSLA","CBOO","LU1564329628.SGD","CBTA","AMDL","LU1935043536.SGD","LU0070302665.USD","LU0957808578.USD","IE00BKVL7J92.USD","IE0034235188.USD","LU2347655073.USD","LU0072462426.USD","LU0742534661.SGD","TSDD","ILDR","THNR","LU1674673428.USD","BK4573","IE00BK4W5L77.USD","LU1951198990.SGD","LU1861215975.USD","LU0187121727.USD","IE0005OL40V9.USD","TEST","LU0308772762.SGD","LU2543165471.USD","USXF","LU0203202063.USD","DRIV","LU1670711040.USD","LU1670627923.USD","METQ","BPI","IE000KEQY171.SGD","NVOX","LU2505996681.GBP","BK4598","BK4077","LU2247934214.USD","BK4511","LU1935042488.USD","LU0949170426.SGD","ARKB","LU0211328371.USD","LU0320765059.SGD","BK4023","LU1718418525.SGD","SG9999014880.SGD","SINTCmain","LU0661504455.SGD","LU2360107168.USD","LU0011850046.USD","CBTY","LU1116320737.USD","AMDG","BK4507","IE00BQXX3C00.GBP","SBIT","LU0053666078.USD","LU2360032135.SGD","LU1935042215.USD","LU1868836591.USD","IBIT","LU1116320901.HKD","LU0251132253.USD","BK4604","LU2272731600.USD","SG9999018865.SGD","IE000SO60NU8.SGD","SG9999017495.SGD","BK4585","BK4579","IE00BQXX3D17.EUR","IE00B19Z3B42.SGD","XDAT","IE00BFSS7M15.SGD","BK4555","LU0672654240.SGD","BK4575","LU1551013425.SGD","LU0949170772.SGD","CBOA","LU2456880835.USD","BTCW","IE000BZT7R73.USD","PPH","BAI","LU0211327993.USD","BK4516","LU0738911758.USD","BK4612","LU1923623000.USD","LU1267930813.SGD","LU1435385759.SGD","LU1974910355.USD","LU1629891620.HKD","LU0889565833.HKD","LU0061474705.USD","BITI","LU0553294199.USD","LU1989764748.USD","LU1868836757.USD","LU2168564495.EUR","LU0726765562.USD","LU0320765489.SGD","IE000F7OJYX1.SGD","LU0784385170.HKD","AMDW","LU0345769631.USD","SG9999014898.SGD","07366","IE00BN29S564.USD","BK4554","LIT","LU1839511570.USD","LU0354030438.USD","LU2242649171.HKD","LU2750360997.AUD","LU0096362180.USD","QBF","LU2756315664.SGD","BK4605","SOCL","LU0390134368.USD","LU1003077747.HKD","LU2361044949.HKD","BITB","AMDS","LU0198837287.USD","LU0203347892.USD","LU2249611893.SGD","LU2592432038.USD","LU0795875169.SGD","LU0079474960.USD","IE00B19Z9505.USD","BFAP","NVO","LU2471134796.USD","BK4587","LU2098885051.SGD","LU2347655156.SGD","ARTY","BTC","IE00BJTD4N35.SGD","LU0642271901.SGD","BTC.USD.CC","IE00B7KXQ091.USD","LU0345770308.USD","LU0784383803.USD","LU1989772840.SGD","XNTK","BK4515","LU0225283273.USD","FBYY","LU1242518857.USD","SG9999001077.SGD","LU0985320562.USD","LU2322448791.USD","IE0000B7K699.USD","CHPS","LU2430703251.USD","LU0276348264.USD","LU1988902786.USD","METD","TSLS","FBX","LU1868837136.USD","LU0106261372.USD","AIQ","LU1548497426.USD","LU1084165304.USD","LU0477156953.USD","LU1852331112.SGD","LU0957791311.USD","RSPC","LU0648001328.SGD","LU0889566641.SGD","LU0265550946.USD","LU2054465674.USD","BK4614","FAI","LU0719512351.SGD","LU1992135399.USD","LU0052756011.USD","LU2213496289.HKD","TSLZ","LU1066051811.HKD","LU1035775433.USD","IE0004445239.USD","LU1235294995.USD","LU2764263039.SGD","SGXZ81514606.USD","BK4524","IE00B4JS1V06.HKD","BTCI","LU0820561818.USD","LU1732800096.USD","BK4125","LU0979878070.USD","LU1804176565.USD","LU2357627491.SGD","LU2417539215.USD","BK4548","LU0157215616.USD","IE00B775H168.HKD","LU0321505868.SGD","IE000WAW04H5.SGD","LU2462591350.SGD","IE00BJLML261.HKD","EZBC","FCOM","LINT","LU0943347566.SGD","IE00B1XK9C88.USD","LU2264538146.SGD","TSL","LU1366333091.USD","LU2602419157.SGD","LU1861559042.SGD","LU0823421416.USD","LU2168563687.JPY","LU1670710661.SGD","LU1066051225.USD","LU1551013342.USD","TSLO","LU1496350502.SGD","BK4550","LU2552382132.HKD","STSLAmain","LU0316494557.USD","BITY","LU1989772923.USD","WANT","BK4534","BK4599","LU0256863902.USD","LU0690374961.EUR","LU1868837300.USD","LU2403377893.USD","LU2461242641.AUD","LU1803068979.SGD","TSLW","WUGI","LU1232071149.USD","LU0267386448.USD","BK4099","SGXZ23171101.USD","LU1697837992.HKD","LU2108987350.USD","IE00B7SZLL34.SGD","LU0234572021.USD","LU0912757837.SGD","LU0345769128.USD","BK4535","TSLL","BK4512","LU1917777945.USD","LU2746668461.USD","LU2750360641.GBP","TSYY","LU0251131958.USD","LU2931357623.SGD","LU2237957811.SGD","GB00B4LPDJ14.GBP","LU0127658192.USD","LU0980610538.SGD","BK4533","LU0878866978.SGD","SG9999001424.SGD","NVOC","LU2326559502.SGD","TTEQ","LU1720051108.HKD","LU2250418816.HKD","09766","LU1564329461.SGD","LU0109391861.USD","INT","IE00BFSS8Q28.SGD","LU2133065610.SGD","BTCC","LU2361045086.USD","LU0820562030.AUD","LU0274383776.USD","LU0640476718.USD","BTCO","LU2023250330.USD","LU2896262040.SGD","PARA","TSLP","CBXY","BTF","FBTC","LU1642822529.SGD","LU2381873111.SGD","LU2272731865.HKD","AMDY","TRUC","LU1791710582.SGD","LU1935043452.HKD","BETH","LU2087621335.USD","LU2471134879.HKD","LU1868836914.USD","TSLY","AMYY","BK4543","LU0314104364.USD","LU0048584097.USD","SG9999014914.USD","SMHX","LU0683600562.USD","FDRV","CBTO","BFJL","09366","SAMD0main","LU0985489474.SGD","BETE","LU0109392836.USD","LU0234570918.USD","LU0786609619.USD","TSLI","LU2125154935.USD","LU0545039389.USD","LU1059921491.USD","AMDD","LU1145028129.USD","SMH","LU2764263203.CNY","LU1791710400.SGD","LU2065169927.USD","IE00BZ1G4Q59.USD","SG9999002224.SGD","HK0000914686.HKD","TLA","LU2756315318.SGD","LU2430703095.HKD","FBL","BITO","IE000ITXATA3.USD","XLC","LU2458330169.SGD","METV","IE0001KFT4U8.USD","LU1935043023.USD","SG9999015952.SGD","BITU","INYY","LU1992135472.HKD","BK4108","IE000YTNTUN2.SGD","LU0345770993.USD","SGXZ80539844.SGD","LU1571399168.USD","LU0417517546.SGD","LU0354030511.USD","LU1153585028.USD","LU2552382215.SGD","CBXA","LU0133085943.USD","LEGR","LU0215105999.USD","INTC","LU2065170008.USD","LU0466842654.USD","DAMD","LU0048573561.USD","SOXY","LU2462157665.USD","LU1261432733.SGD","LU0795875086.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669451651","title":"Novo Nordisk Investor Day Disappointed","url":"https://stock-news.laohu8.com/highlight/detail?id=2669451651","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669451651?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:39","pubTimestamp":1790073540,"startTime":"0","endTime":"0","summary":"1038 GMT - Novo Nordisk's capital markets day announcements, including the diversification plan and a vague midterm sales target, disappointed investors, AlphaValue analyst Abhishek Raval writes. \"Against the backdrop of excessive dependency on a single molecule, aggressive and heavy diversification bets, along with impeccable commercial execution, are the need of the hour.\" However, the markets have their reservations, Raval says. The commercial success of oral Wegovy, some promising late-stage assets, and the firepower for acquisitions provide reasons to bet on Novo, which is available at a discount to peers, he adds. AlphaValue rates the Danish drugmaker's stock at buy with a 450 Danish kroner target price. Shares fall 0.2% to 259.40 kroner.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4532","NVOH","LU1093756168.USD","NVOC","IE00BZ1G4Q59.USD","LU0154236417.USD","PPH","IE00BKVL7J92.USD","BK4588","BK4585","LU1093756325.SGD","OZEM","BK4599","NVOX","THNR","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669713148","title":"Market Chatter: Novo Nordisk CEO Eyes M&A to Fill Gaps in Drug Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2669713148","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669713148?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:52","pubTimestamp":1790070723,"startTime":"0","endTime":"0","summary":"Novo Nordisk  Chief Executive Mike Doustdar said the pharmaceutical major is considering acquisitions to bolster its position in the weight-loss drug market, CNBC reported Tuesday, citing an interview.Doustdar said Novo Nordisk will look for weaknesses in its drug lineup and consider acquisitions of treatments that could help close those gaps, CNBC reported.Doustdar said that the market reaction to its new long-term strategy and growth targets showed that the company still has work to do in convincing some investors.Novo Nordisk did not immediately reply to MT Newswires' request for comment.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","NVOH","BK4532","NVOC","PPH","BK4585","NVO","BK4599","OZEM","LU0154236417.USD","NVOX","IE00BKVL7J92.USD","THNR","BK4007","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143804","title":"Novo Stock (NVO): Deutsche Bank Keeps Sell Rating, Says Growth Strategy ‘Underwhelming on Multiple Fronts’","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143804","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143804?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:43","pubTimestamp":1790070183,"startTime":"0","endTime":"0","summary":"Novo shares fell 7.96% to $39.80 on Monday after its growth strategy, disclosed at its Capital Markets Day in London, failed to impress investors\n...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-stock-nvo-deutsche-bank-keeps-sell-rating-says-growth-strategy-underwhelming-on-multiple-fronts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-stock-nvo-deutsche-bank-keeps-sell-rating-says-growth-strategy-underwhelming-on-multiple-fronts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","PPH","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4588","THNR","LU1093756168.USD","NVO","BK4532","BK4585","BK4007","BK4599","NVOX","OZEM","NVOH","IE00BKVL7J92.USD","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669486461","title":"Novo Nordisk (0QIU) Receives a Hold from Berenberg Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669486461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:15","pubTimestamp":1790068532,"startTime":"0","endTime":"0","summary":"In a report released today, Kerry Holford from Berenberg Bank maintained a Hold rating on Novo Nordisk, with a price target of DKK305.00. Holford c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-berenberg-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-berenberg-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPH","BK4532","NVO","BK4588","NVOX","IE00BZ1G4Q59.USD","LU1093756168.USD","OZEM","BK4599","BK4007","LU0154236417.USD","BK4585","THNR","NVOC","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669110697","title":"Novo Nordisk Investors Remain Nervous, but Share Drop an Overreaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2669110697","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669110697?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:11","pubTimestamp":1790068260,"startTime":"0","endTime":"0","summary":"0909 GMT - Novo Nordisk's 8% share price fall following the investor day is an overreaction, but proves that investors remain nervous about 2027, with expected price pressure and CagriSema drug launch skepticism, Berenberg analysts write. The Novo story appears more interesting from 2028, with zenagamtide phase 3 data, CagriSema bone and muscle function data and multiple phase 1 and 2 readouts, the bank says. The event provided a comprehensive overview of the company's strategy, R&D pipeline and business operations, but offered only incremental strategic insights, it adds. The 2030 and 2035 sales ambitions were also outlined, which are broadly in line with expectations. Understanding the need to quickly diversify the portfolio ahead of U.S./EU semaglutide patent expiry early next decade, Novo aims to significantly speed up development and supplement the internal pipeline. Shares fall 0.7%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","NVOC","LU1093756325.SGD","OZEM","NVOH","NVOX","PPH","BK4585","BK4588","BK4007","NVO","LU0154236417.USD","THNR","BK4599","LU1093756168.USD","BK4532","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141741","title":"Novo Nordisk's Underwhelming Investor Day Met with Punishing Response","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141741","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141741?lang=en_us&edition=fundamental","pubTime":"2026-09-22 15:41","pubTimestamp":1790062860,"startTime":"0","endTime":"0","summary":"0740 GMT - Novo Nordisk's investor day underwhelmed on multiple fronts, relative to some of the more optimistic expectations heading into the event, Deutsche Bank analyst Emmanuel Papadakis writes. \"Whilst the event provided both a helpful and thorough review of the business outlook as well as a strategic refresh, it was met with a fairly punishing market response.\" The bank says there was largely a reiteration of familiar strategic messaging and the mid-term building blocks, in addition to somewhat underwhelming mid-term guidance. There was also nothing of substance in terms of clinical data or assets, and little clarity on M&A even though it clearly remains on the agenda, Deutsche Bank adds. The bank lowers its stock target price to 245 Danish kroner from 265 kroner and retains its sell rating. Shares fall 0.6% to 258.50 kroner.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NVO","LU1093756168.USD","LU0154236417.USD","PPH","BK4007","NVOC","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4532","OZEM","LU1093756325.SGD","NVOH","BK4599","BK4585","NVOX","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669116407","title":"Novo Nordisk's Share Fall After Investor Day Seems Harsh","url":"https://stock-news.laohu8.com/highlight/detail?id=2669116407","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669116407?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:16","pubTimestamp":1790057760,"startTime":"0","endTime":"0","summary":"0616 GMT - Novo Nordisk's 8% share decline following the Wegovy maker's investor day on Monday suggests investors weren't convinced about its growth plans, but this seems like a somewhat harsh reaction, Jyske Bank's Henrik Hallengreen Laustsen writes. \"The strategy and its key components appear sound, if not impressive.\" However, following several disappointments from Novo, the market wants to see concrete clinical and commercial evidence, Jyske Bank adds. Novo presented ambitions for industry-level growth through 2030 and stable margins, which seemed slightly underwhelming relative to market expectations, the bank says. It maintains its hold rating on the stock with a 330 Danish kroner target price.Jyske Bank cites uncertainty on growth prospects, pressure from semaglutide's 2032 patent expiry, fair valuation, and limited near-term news flow. Shares closed Monday at 260 kroner.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","BK4532","IE00BKVL7J92.USD","BK4588","BK4585","LU1093756168.USD","NVO","NVOC","BK4007","NVOH","OZEM","THNR","NVOX","LU1093756325.SGD","BK4599","IE00BZ1G4Q59.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}